Free Trial Information
BioCentury | Jan 28, 2020
Distillery Therapeutics

Inhibiting CD36 to overcome resistance to Tykerb in HER2-positive breast cancer

...Rep. ; published online Dec. 10, 2019 doi:10.1016/j.celrep.2019.11.008 CONTACT: Manabu Kurokawa, Dartmouth College, Hanover, N.H.; Kent State University...
Read More
BioCentury | Jan 16, 2001
Clinical News

Pathogen diagnostic system regulatory update

Kent State University and Northeastern Ohio Universities College of Medicine received U.S. Patent No. 6,171,802 covering the use of liquid crystals for the detection of pathogens such as bacteria and viruses. The technology is licensed...
Read More
Items per page:
1 - 2 of 2
BioCentury | Jan 28, 2020
Distillery Therapeutics

Inhibiting CD36 to overcome resistance to Tykerb in HER2-positive breast cancer

...Rep. ; published online Dec. 10, 2019 doi:10.1016/j.celrep.2019.11.008 CONTACT: Manabu Kurokawa, Dartmouth College, Hanover, N.H.; Kent State University...
Read More
BioCentury | Jan 16, 2001
Clinical News

Pathogen diagnostic system regulatory update

Kent State University and Northeastern Ohio Universities College of Medicine received U.S. Patent No. 6,171,802 covering the use of liquid crystals for the detection of pathogens such as bacteria and viruses. The technology is licensed...
Read More
Items per page:
1 - 2 of 2